Prognostic implications of determining 180 kDa bullous pemphigoid antigen (BPAG2) gene/protein pathology in neonatal junctional epidermolysis bullosa

British Journal of Dermatology

Volumn 138, Issue 4, 1998, Pages 661-666

  Mellerio, J E ^a   Denyer, J E ^b   Atherton, D J ^b   Eady, R A J ^a   McGrath, J A ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b G Ormond Str Hosp Sick Children   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN;

ANTIGEN DETECTION; ARTICLE; BLISTER; BULLOUS SKIN DISEASE; CASE REPORT; CLINICAL FEATURE; EPIDERMOLYSIS BULLOSA; FAILURE TO THRIVE; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; NEWBORN; NEWBORN DISEASE; PATIENT COUNSELING; PRIORITY JOURNAL; PROGNOSIS; SKIN BIOPSY;

AUTOANTIGENS; CARRIER PROTEINS; COLLAGEN; CYTOSKELETAL PROTEINS; EPIDERMOLYSIS BULLOSA, JUNCTIONAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; INFANT, NEWBORN; MUTATION; NERVE TISSUE PROTEINS; NON-FIBRILLAR COLLAGENS; PEDIGREE; PROGNOSIS;

EID: 0031895904     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1998.02182.x     Document Type: Article

References (28)

1. Fine J-D, Bauer EA, Briggaman RA et al. Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa: a consensus report by the subcommittee on diagnosis and classification of the National Epidermolysis Bullosa Registry. J Am Acad Dermatol 1991; 24: 119-35.
2. Eady RAJ, Tidman MJ. Diagnosing epidermolysis bullosa. Br J Dermatol 1983; 108: 621-6.
3. Christiano AM, Uitto J. Molecular complexity of the cutaneous basement membrane zone: revelations from paradigms of epidermolysis bullosa. Exp Dermatol 1996; 5: 1-11.
4. McGrath JA, Gatalica B, Christiano AM et al. Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a transmembrane hemidesmosomal collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa. Nature Genet 1995; 11: 83-6.
5. Kennedy AR, Heagerty AHM, Ortonne J-P et al. Abnormal binding of an anti-amnion antibody to epidermal basement membrane provides a novel diagnostic probe for junctional epidermolysis bullosa. Br J Dermatol 1985; 113: 651-9.
6. Eady RAJ. Transmission electron microscopy. In: Methods in Skin Research (Skerrow D, Skerrow CJ, eds). Chichester: John Wiley and Sons. 1985; 1-35.
7. Verrando P, Blanchet-Bardon C, Pisani A et al. Monoclonal antibody GB3 defines a widespread defect of several basement membranes and a keratinocyte dysfunction in patients with lethal junctional epidermolysis bullosa. Lab Invest 1991; 64: 85-92.
8. Nishizawa Y, Uematsu J, Owaribe K. HD4 a 180-kD bullous pemphigoid antigen, is a major transmembrane glycoprotein of the hemidesmosome. J Biochem (Tokyo) 1993; 113: 493-501.
9. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. A Laboratory Manual. Cold Spring Harbor. NY. Cold Spring Harbor Laboratory Press, 1989.
10. Gatalica B, Pulkkinen L, Li K et al. Cloning of the human type XVII collagen gene (COL17A1): and detection of novel mutations in generalized atrophic benign epidermolysis bullosa. Am J Hum Genet 1997; 60: 352-65.
11. Ganguly A, Rock MJ, Prockop DJ. Conformation-sensitive gel electrophoresis for rapid detection of single base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes. Pror Natl Acad Sci USA 1993; 90: 10325-9.
12. Pulkkinen L, Kimonis VE, Xu Y et al. Homozygous ah integrin mutation in junctional epidermolysis bullosa with congenital duodenal atresia. Hum Mol Genet 1997; 6: 669-74.
13. Pulkkinen L, Christiano AM, Gerecke D et al. A homozygous nonsense mutation in the β3 chain gene of laminin 5 (LAMB3) in Herlitz junctional epidermolysis bullosa. Genomics 1994; 24: 357-60.
14. Pulkkinen L, McGrath JA, Christiano AM, Uitto J. Detection of sequence variants in the gene encoding the β3 chain of laminin 5 (LAMB3). Hum Mutat 1995; 6: 77-84.
15. Vailly J, Pulkkinen L, Miquel C et al. Identification of a homozygous one-basepair deletion in exon 14 of the LAMB3 gene in a patient with Herlitz junctional epidermolysis bullosa and prenatal diagnosis in a family at risk for recurrence. J Invest Dermatol 1995; 104: 462-6.
16. Kivirikko S, McGrath JA, Pulkkinen L et al. Mutational hotspots in the LAMB3 gene in the lethal (Herlitz) type of junctional epidermolysis bullosa. Hum Mol Genet 1996; 5: 231-7.
17. McGrath JA, Kivirikko S, Ciatti S et al. A recurrent homozygous nonsense mutation within the LAMA3 gene as a cause of Herlitz junctional epidermolysis bullosa in patients of Pakistani ancestry: evidence for a founder effect. J Invest Dermatol 1996; 106: 781-4.
18. McGrath JA, Pulkkinen L, Christiano AM et al. Altered laminin 5 expression due to mutations in the gene encoding the β 3 chain (LAMB3) in generalized atrophic benign epidermolysis bullosa. J Invest Dermatol 1995; 104: 467-74.
19. McGrath JA, Christiano AM, Pulkkinen L et al. Compound heterozygosity for nonsense and missense mutations in the LAMB 3 gene in nonlethal junctional epidermolysis bullosa. J Invest Dermatol 1996; 106: 775-7.
20. McGrath JA, Darling T, Gatalica B et al. A homozygous deletion mutation in the gene encoding the 180-kDa bullous pemphigoid antigen (BPAG2) in a family with generalized atrophic benign epidermolysis bullosa. J Invest Dermatol 1996; 106: 771-4.
21. McGrath JA, Gatalica B, Li K et al. Compound heterozygosity for a dominant glycine substitution and a recessive internal duplication mutation in the type XVII collagen gene results in junctional epidermolysis bullosa and abnormal dentition. Am J Pathol 1996; 148: 1787-96.
22. Chavanas S, Gache Y, Tadini GL et al. A homozygous in-frame deletion in the collagenous domain of bullous pemphigoid antigen BP180 (type XVII collagen) causes generalized atrophic benign epidermolysis bullosa. J Invest Dermatol 1997; 109: 74-8.
23. Darling T, McGrath JA, Yee C et al. Premature termination codons are present on both alleles of the bullous pemphigoid antigen 2/ type XVII collagen gene in live Austrian families with generalized atrophic benign epidermolysis bullosa. J Invest Dermatol 1997; 108: 463-8.
24. Hintner H, Wolff K. Generalized atrophic benign epidermolysis bullosa. Arch Dermatol 1982; 118: 375-84.
25. Paller AS, Fine JD, Kaplan S, Pearson W. The generalized atrophic benign form of junctional epidermolysis bullosa. Arch Dermatol 1986; 122: 704-10.
26. Urlaub G, Mitchell PJ, Ciudad CJ, Chasin LA. Nonsense mutations in the dihydrofolate reductase gene affect RNA processing. Mol Cell Biol 1989; 9: 2868-80.
27. Cheng J. Fogel-Petrovic M, Maquat LE. Translation to near the distal end of the penultimate exon is required for normal levels of spliced triosephosphate isomerase mRNA. Mol Cell Biol 1990; 10: 5215-25.
28. Cooper DN. Human gene mutations affecting RNA processing and translation. Ann Med 1993; 25: 11-17.